| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
9,062.25
|
|
Change (%)
|
-12.30 (-0.14%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
9,048.00
-
9,165.90
|
|
52-Week Range (RS)
|
6,301.00
-
10,653.05
|
|
Beta (1 Year)
|
0.38
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| AstraZeneca Pharma gets CDSCO nod for import and sale of Datverzo in India |
| AstraZeneca partners with Sun Pharma for second SZC brand in India |
| Astrazeneca Pharma and Sun Pharma form second brand partnership |
| AstraZeneca Pharma slides after Q2 PAT decline 2% QoQ |
| Astrazeneca Pharma India standalone net profit rises 41.09% in the September 2025 quarter |
| Astrazeneca Pharma India to discuss results |
| Astrazeneca Pharma India Ltd - Launch Of Sodium Zirconium Cyclosilicate Powder For Oral Suspension 5G (Lokelma) |
| AstraZeneca Pharma gets CDSCO nod for Enhertu |
| Astrazeneca Pharma India Ltd - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) ... |
| AstraZeneca Pharma India announces resignation of Head - Legal |
|
|
|
| Incoporation Year : 1979 |
| Chairman : Shilpa Divekar Nirula |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Astrazeneca Pharma India Ltd
Blk N1 12th Flr Manyata Embass,
Rachenahalli Outer Ring Road,
Bangalore,
Karnataka-560045 |
Phone:91-080-67748000
Fax:91-080-67748557 |
| E-Mail : comp.secy@astrazeneca.com |
| URL : http://www.astrazeneca.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
12-Dec-2025 |
9138.35 |
-0.83 |
| 1Month |
19-Nov-2025 |
9116.60 |
-0.60 |
| 3Month |
19-Sep-2025 |
8938.20 |
1.39 |
| 6Month |
19-Jun-2025 |
9422.95 |
-3.83 |
| 1Year |
19-Dec-2024 |
6505.85 |
39.29 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Nippon India Small Cap Fund |
0.87 |
593.85 |
| Bandhan Large & Mid Cap Fund |
0.68 |
87.34 |
| Bandhan Innovation Fund |
3.63 |
70.56 |
| Nippon India Pharma Fund |
0.67 |
56.46 |
| ICICI Pru Quality Fund |
2.29 |
53.29 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
28,039.30 |
0.59 |
35,921.55 |
25,260.20 |
59,583.51 |
| Glaxosmithkline Pharmaceuticals Ltd |
2,534.60 |
-0.70 |
3,515.95 |
1,924.30 |
42,937.65 |
| Pfizer Ltd |
5,099.20 |
0.00 |
5,987.65 |
3,742.90 |
23,327.68 |
| Sanofi Consumer Healthcare India Ltd |
4,590.15 |
-0.40 |
5,954.00 |
4,360.30 |
10,571.40 |
| Procter & Gamble Health Ltd |
5,648.60 |
-0.23 |
6,700.00 |
4,916.00 |
9,376.33 |
|
|
|
|